Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577966 · ClinicalTrials.gov registry record · NA
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01577966 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 9 participants.
The verdict
NCT01577966, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The main purpose of this part of the study is to determine the Central Nervous System bioavailability of sulfasalazine.
Interventions
- DRUG Sulfasalazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01577966
The ClinicalTrials.gov registry entry for NCT01577966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sulfasalazine is the first listed.
NCT01577966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01577966 about?
NCT01577966 is a clinical study titled "Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma". The main purpose of this part of the study is to determine the Central Nervous System bioavailability of sulfasalazine.
What is the current status of trial NCT01577966?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01577966?
The interventions under investigation include: Sulfasalazine (DRUG).
Who is sponsoring clinical trial NCT01577966?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.